{
  "kind": "notePage",
  "slug": "pricing-ambiguity-creates-comparison-fatigue",
  "title": "Pricing ambiguity creates comparison fatigue",
  "summary": "Pricing interpretation cost is quietly damaging otherwise promising evaluations. In the current 334-company cohort, 23 of 334 companies made it the main blocker, while 276 of 334 showed at least one public signal for it.",
  "canonicalUrl": "https://archive.citrusgate.com/notes/pricing-ambiguity-creates-comparison-fatigue",
  "markdownUrl": "https://archive.citrusgate.com/notes/pricing-ambiguity-creates-comparison-fatigue.md",
  "jsonUrl": "https://archive.citrusgate.com/api/public/notes/pricing-ambiguity-creates-comparison-fatigue.json",
  "publishedAt": "2026-04-28",
  "tags": [
    "pricing",
    "ambiguity"
  ],
  "policy": {
    "canonicalUrl": "https://archive.citrusgate.com/about",
    "markdownUrl": "https://archive.citrusgate.com/about.md",
    "author": {
      "name": "Ivan Golovach",
      "title": "Founder and brief lead",
      "summary": "Ivan Golovach built and operates the CitrusGate workflow, holds the release stop-line on the private memo, and answers fit questions directly. The service is sold on inspectable work, clear boundaries, and one accountable operator."
    },
    "entity": {
      "name": "CitrusGate LLC",
      "summary": "The operating entity behind the site, the Stripe checkout, and the private brief release."
    },
    "editorialBoundary": {
      "summary": "CitrusGate publishes public proof, not raw company notes. The site shows how the diagnosis thinks without exposing the company-specific correction that belongs in private delivery.",
      "bullets": [
        "Public pages show public-safe proof, dated recurrence, and blocker framing.",
        "They do not show raw company notes or the private next move for one team.",
        "Published counts refer to the current public release, not every private company the workflow has touched.",
        "The first commercial product is the fixed-scope Decision Friction Brief."
      ]
    },
    "privacyBoundary": {
      "summary": "If a piece of information only makes sense when the reader knows the exact company, contact, or outreach context, it stays private. CitrusGate does not repurpose client-specific brief detail onto the public site unless it has been fully abstracted and made public-safe.",
      "bullets": [
        "Private data bundles, admin routes, and raw company-level research stay out of the public layer.",
        "Only public-safe artifacts that become clearer after abstraction belong in the machine-readable corpus."
      ]
    },
    "usage": {
      "publicReadOnly": true,
      "searchDiscoveryAllowed": true,
      "trainingAllowed": false,
      "vendorAccess": {
        "googleSearch": true,
        "googleExtended": true,
        "bingSearch": true,
        "openAiSearch": true,
        "openAiUserFetch": true,
        "openAiTraining": false,
        "anthropicSearch": true,
        "anthropicUserFetch": true,
        "anthropicTraining": false,
        "perplexitySearch": true,
        "perplexityUserFetch": true
      },
      "writeActionsAvailable": true,
      "privateResearchExposed": false,
      "publicAskAvailable": true,
      "mcpAvailable": false
    }
  },
  "timestamps": {
    "machineGeneratedAt": "2026-05-02T21:38:17Z",
    "canonicalLastModifiedAt": "2026-04-28",
    "publishedAt": "2026-04-28"
  },
  "body": "# Pricing ambiguity creates comparison fatigue\n- Published: 2026-04-28\n- Tags: pricing, ambiguity\n- Canonical: https://archive.citrusgate.com/notes/pricing-ambiguity-creates-comparison-fatigue\nPricing interpretation cost is quietly damaging otherwise promising evaluations. In the current 334-company cohort, 23 of 334 companies made it the main blocker, while 276 of 334 showed at least one public signal for it.\n## Observation\n- 276 of 334 companies showed at least one public signal for this blocker.\n- If buyers have to decode units and packages, comparison gets heavier before value is clear.\n- 273 of 276 paired it with decision drift, which is why the public note stops at diagnosis instead of publishing the full next move.\n## Closing\nPricing clarity does not replace product value, but it often determines whether value gets compared cleanly. The brief keeps the deeper TCO logic, pricing traps, and company-specific commercial diagnosis private.\n## Related Themes\n- In this cohort, the pricing blocker was often metric legibility. (https://archive.citrusgate.com/themes/pricing-ambiguity)",
  "sections": [
    {
      "title": "Summary",
      "body": "Pricing interpretation cost is quietly damaging otherwise promising evaluations. In the current 334-company cohort, 23 of 334 companies made it the main blocker, while 276 of 334 showed at least one public signal for it."
    },
    {
      "title": "Observation",
      "bullets": [
        "276 of 334 companies showed at least one public signal for this blocker.",
        "If buyers have to decode units and packages, comparison gets heavier before value is clear.",
        "273 of 276 paired it with decision drift, which is why the public note stops at diagnosis instead of publishing the full next move."
      ]
    },
    {
      "title": "Closing",
      "body": "Pricing clarity does not replace product value, but it often determines whether value gets compared cleanly. The brief keeps the deeper TCO logic, pricing traps, and company-specific commercial diagnosis private."
    }
  ],
  "related": {
    "themes": [
      {
        "title": "In this cohort, the pricing blocker was often metric legibility.",
        "canonicalUrl": "https://archive.citrusgate.com/themes/pricing-ambiguity",
        "markdownUrl": "https://archive.citrusgate.com/themes/pricing-ambiguity.md",
        "jsonUrl": "https://archive.citrusgate.com/api/public/themes/pricing-ambiguity.json",
        "summary": "In the selected cohort, pricing-ambiguity evidence appeared across 276 companies and 286 signals. In these selected cases, the blocker was often not the price level itself; it was uncertainty about the metric, forecast, expansion trigger, or enterprise requirement that would define the real cost."
      }
    ]
  }
}